PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 1, 20260 citationsOpen Access

Advances in Diagnosis and Management of Pulmonary Arterial Hypertension: A Systematic Review

View Full Paper
*B*Sreenu Thalla, Shaik Shannu, M. Jahnavi, K. Bala Jyothi, V. Lakshmi Venkata Sai, I. Jaswanthi, P. Siva Krishna, P. Srinivasa Babu

Key Result

A systematic review of 72 studies demonstrated significant improvements in early diagnosis of pulmonary arterial hypertension through multimodal imaging, biomarkers, and genetic screening.

Key Points

  • This review aims to summarize recent advancements in the diagnosis and management of pulmonary arterial hypertension (PAH).
  • Conducted systematic literature review according to PRISMA 2020 guidelines.
  • Searched electronic databases for studies published from 2015 to 2025.
  • Included 72 studies meeting eligibility criteria.
  • Significant improvements in early diagnosis using cardiac MRI and AI-assisted echocardiography.
  • Enhanced individual risk assessment and precision medicine approaches observed.
  • Refined hemodynamic assessment contributes to better long-term outcomes.

Study Design

Type

Systematic Review

Structured PICO

P
Population
Systematic review of 72 studies evaluating advances in the diagnosis and management of pulmonary arterial hypertension.
E
Exposure
Advances in diagnosis (multimodal imaging, cardiac MRI, AI-assisted echocardiography, circulating biomarkers, genetic screening, refined hemodynamic assessment) and management

This systematic review highlights recent advances in the early diagnosis and management of pulmonary arterial hypertension, emphasizing multimodal imaging, biomarkers, and precision medicine.

Abstract

Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disorder characterized by elevated pulmonary arterial pressure and pulmonary vascular resistance, ultimately resulting in right ventricular failure and premature mortality. Despite its rarity, PAH remains associated with significant morbidity and mortality due to delayed diagnosis and rapid disease progression. A systematic literature review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines. Electronic databases including PubMed, Scopus, Web of Science, Embase, and Google Scholar were searched for studies published between January 2015 and December 2025. Search terms included "Pulmonary arterial hypertension," "Diagnosis," "Right heart catheterization," "Biomarkers," "Cardiac MRI," "Combination therapy," "Sotatercept," and "Management." Original research articles, randomized controlled trials, systematic reviews, meta-analyses, and international clinical practice guidelines published in English were included. Following screening and eligibility assessment, 72 studies fulfilled the inclusion criteria. Recent evidence demonstrates significant improvements in early diagnosis through multimodal imaging, cardiac magnetic resonance imaging, artificial intelligence-assisted echocardiography, circulating biomarkers, genetic screening, and refined hemodynamic assessment. Earlier diagnosis, individualized risk assessment, and precision medicine approaches are expected to further optimize long-term outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

*Sreenu Thalla, Shaik Shannu, M. Jahnavi, K. Bala Jyothi, V. Lakshmi Venkata Sai, I. Jaswanthi, P. Siva Krishna, P. Srinivasa Babu (2026) conducted a systematic review in Pulmonary arterial hypertension. Diagnostic and management strategies was evaluated. A systematic review of 72 studies demonstrated significant improvements in early diagnosis of pulmonary arterial hypertension through multimodal imaging, biomarkers, and genetic screening.

synapsesocial.com/papers/6a6d98aae258b358b3c6c4cehttps://doi.org/10.5281/zenodo.21702499
Ask AI
Helpful
Bookmark
Share
View Full Paper